Global Molecular Diagnostics Market Outlook 2020
Molecular diagnostics has revolutionized the healthcare industry by providing more rapid, sensitive and specific diagnostic tests in contrast to the traditional techniques. Since its inception, the molecular diagnostics has witnessed various technological advancements which have made this technique more efficient and effective. With growing awareness and adoption of this sophisticated technique, the molecular diagnostic market is expected to surge in the future.
According to a new analysis from RNCOS in 'Global Molecular Diagnostics Market Outlook 2020” report, the Global Molecular Diagnostics Market is anticipated to grow at a healthy CAGR of 10.8% during the forecast period (2015 to 2020). The market growth is expected mainly due to the growing incidences of cancer and infectious diseases, and increasing awareness about personalized medicine and biomarkers. Furthermore, the improving reimbursement scenario and strategic alliances among major players are other factors driving the growth of the market. There are also various opportunities present for the new incumbents into the market which include overall growth of interest in genetic testing and rise of emerging markets. The report provides information on the current scenario, market outlook on the basis of application, technology and geography, and future forecasts on all prominent segments of the industry till 2020.
According to the analysis by RNCOS, the infectious diseases segment dominates the molecular diagnostics market by application; however it is the oncology segment which is expected to witness the maximum growth in the coming years. This high growth is likely to be driven by the increasing incidences of cancer and growing awareness of the new sophisticated tests available for early cancer detection. Similarly, PCR dominates the molecular diagnostics market by technology and the DNA Sequencing and Next Generation Sequencing (NGS) segment is expected to witness the maximum growth. This growth could be attributed to the availability of cost effective sequencing methods. In terms of geography, North America continues to dominate the market, but it is the Asia Pacific market, which is expected to witness the highest growth, largely due to improving medical facilities and increasing focus of various players in this region.
The later part of the report focuses on existing competition in the industry. Major players operating in this market include Roche Diagnostics, Abbott Diagnostics, Becton Dickinson, and Hologic, among others. The competitive analysis is done at each player level, including their recent developments and a SWOT analysis. To provide a thorough understanding of each player’s business model, the player’s current and historical financials have been analyzed. On the whole, the study included in the report provides a detailed market overview, current and future scenario, and industry trends which will likely generate key interest in investors thinking about joining the industry.
According to a new analysis from RNCOS in 'Global Molecular Diagnostics Market Outlook 2020” report, the Global Molecular Diagnostics Market is anticipated to grow at a healthy CAGR of 10.8% during the forecast period (2015 to 2020). The market growth is expected mainly due to the growing incidences of cancer and infectious diseases, and increasing awareness about personalized medicine and biomarkers. Furthermore, the improving reimbursement scenario and strategic alliances among major players are other factors driving the growth of the market. There are also various opportunities present for the new incumbents into the market which include overall growth of interest in genetic testing and rise of emerging markets. The report provides information on the current scenario, market outlook on the basis of application, technology and geography, and future forecasts on all prominent segments of the industry till 2020.
According to the analysis by RNCOS, the infectious diseases segment dominates the molecular diagnostics market by application; however it is the oncology segment which is expected to witness the maximum growth in the coming years. This high growth is likely to be driven by the increasing incidences of cancer and growing awareness of the new sophisticated tests available for early cancer detection. Similarly, PCR dominates the molecular diagnostics market by technology and the DNA Sequencing and Next Generation Sequencing (NGS) segment is expected to witness the maximum growth. This growth could be attributed to the availability of cost effective sequencing methods. In terms of geography, North America continues to dominate the market, but it is the Asia Pacific market, which is expected to witness the highest growth, largely due to improving medical facilities and increasing focus of various players in this region.
The later part of the report focuses on existing competition in the industry. Major players operating in this market include Roche Diagnostics, Abbott Diagnostics, Becton Dickinson, and Hologic, among others. The competitive analysis is done at each player level, including their recent developments and a SWOT analysis. To provide a thorough understanding of each player’s business model, the player’s current and historical financials have been analyzed. On the whole, the study included in the report provides a detailed market overview, current and future scenario, and industry trends which will likely generate key interest in investors thinking about joining the industry.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. MOLECULAR DIAGNOSTICS - AN INTRODUCTION
4. MARKET DYNAMICS
4.1 Drivers
4.1.1 Rising Incidence of Cancer and Infectious Diseases
4.1.2 Benefits of Molecular Diagnostic Tests Over Traditional Methods
4.1.3 Increasing Awareness of Personalized Medicine, Biomarkers,& Companion Diagnostics
4.1.4 Technological Advancements
4.1.5 Improving Reimbursement Scenario
4.2 Restraints
4.2.1 High Costs of Molecular Diagnostics Tests
4.2.2 Regulatory Issues Related to Molecular Diagnostics Tests
4.3 Trends
4.3.1 Upsurge in the Number of Strategic Alliances
4.3.2 Automation & Multiplexing: A Growing Trend
4.4 Opportunities
4.4.1 Significant Growth Opportunities in Emerging Markets
4.4.2 Genetic Testing: A New Revenue Pocket for Molecular Diagnostics Market
5. MOLECULAR DIAGNOSTICS MARKET OVERVIEW
5.1 Current Market Size and Future Growth
6. MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
6.1 Introduction
6.1.1 Infectious Diseases
6.1.2 Oncology
6.1.3 Blood Screening
6.1.4 Genetic Testing
7. MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
7.1 Introduction
7.1.1 Polymerase Chain Reaction (PCR)
7.1.2 Nucleic Acid Hybridization
7.1.3 DNA Sequencing and Next Generation Sequencing (NGS)
8. MOLECULAR DIAGNOSTIC MARKET, BY REGION
8.1 Introduction
8.1.1 North America
8.1.2 Europe
8.1.3 Asia Pacific
9. KEY PLAYER ANALYSIS
9.1 Abbott Diagnostics (A Division of Abbott Laboratories)
9.2 Alere Inc.
9.3 Becton, Dickinson and Company
9.4 bioMérieux SA
9.5 Cepheid
9.6 Danaher Corporation
9.7 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
9.8 Hologic, Inc.
9.9 QIAGEN N.V.
9.10 Siemens Healthcare
9.11 Thermo Fisher Scientific Inc.
2. RESEARCH METHODOLOGY
3. MOLECULAR DIAGNOSTICS - AN INTRODUCTION
4. MARKET DYNAMICS
4.1 Drivers
4.1.1 Rising Incidence of Cancer and Infectious Diseases
4.1.2 Benefits of Molecular Diagnostic Tests Over Traditional Methods
4.1.3 Increasing Awareness of Personalized Medicine, Biomarkers,& Companion Diagnostics
4.1.4 Technological Advancements
4.1.5 Improving Reimbursement Scenario
4.2 Restraints
4.2.1 High Costs of Molecular Diagnostics Tests
4.2.2 Regulatory Issues Related to Molecular Diagnostics Tests
4.3 Trends
4.3.1 Upsurge in the Number of Strategic Alliances
4.3.2 Automation & Multiplexing: A Growing Trend
4.4 Opportunities
4.4.1 Significant Growth Opportunities in Emerging Markets
4.4.2 Genetic Testing: A New Revenue Pocket for Molecular Diagnostics Market
5. MOLECULAR DIAGNOSTICS MARKET OVERVIEW
5.1 Current Market Size and Future Growth
6. MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
6.1 Introduction
6.1.1 Infectious Diseases
6.1.2 Oncology
6.1.3 Blood Screening
6.1.4 Genetic Testing
7. MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
7.1 Introduction
7.1.1 Polymerase Chain Reaction (PCR)
7.1.2 Nucleic Acid Hybridization
7.1.3 DNA Sequencing and Next Generation Sequencing (NGS)
8. MOLECULAR DIAGNOSTIC MARKET, BY REGION
8.1 Introduction
8.1.1 North America
8.1.2 Europe
8.1.3 Asia Pacific
9. KEY PLAYER ANALYSIS
9.1 Abbott Diagnostics (A Division of Abbott Laboratories)
9.2 Alere Inc.
9.3 Becton, Dickinson and Company
9.4 bioMérieux SA
9.5 Cepheid
9.6 Danaher Corporation
9.7 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
9.8 Hologic, Inc.
9.9 QIAGEN N.V.
9.10 Siemens Healthcare
9.11 Thermo Fisher Scientific Inc.
LIST OF FIGURES:
Figure 5-1: Global - Molecular Diagnostics Market (Billion US$), 2015-2020
Figure 6-1: Global - Molecular Diagnostics Market by Application (%), 2015
Figure 6-2: Global - Molecular Diagnostics Market by Application (%), 2020
Figure 6-3: Global - Infectious Disease Market (Billion US$), 2015-2020
Figure 6-4: Global - Oncology Market (Billion US$), 2015-2020
Figure 6-5: Global - Blood Screening Market (Billion US$), 2015-2020
Figure 6-6: Global - Genetic Testing Market (Billion US$), 2015-2020
Figure 7-1: Global - Molecular Diagnostics Market by Technology (%), 2015
Figure 7-2: Global - Molecular Diagnostics Market by Technology (%), 2020
Figure 7-3: Global - PCR Market (Billion US$), 2015-2020
Figure 7-4: Global - Nucleic Acid Hybridization Market (Billion US$), 2015-2020
Figure 7-5: Global - DNA Sequencing and NGS Market (Billion US$), 2015-2020
Figure 8-1: Global - Molecular Diagnostics Market by Region (%), 2015
Figure 8-2: Global - Molecular Diagnostics Market by Region (%), 2020
Figure 8-3: North America - Molecular Diagnostics Market (Billion US$), 2015-2020
Figure 8-4: North America - Molecular Diagnostics Market by Country (%), 2015
Figure 8-5: Europe - Molecular Diagnostics Market (Billion US$), 2015-2020
Figure 8-6: Europe - Molecular Diagnostics Market by Country (%), 2015
Figure 8-7: Asia Pacific - Molecular Diagnostics Market (Billion US$), 2015-2020
Figure 8-8: Asia Pacific - Molecular Diagnostics Market by Country (%), 2015
Figure 9-1: Abbott Laboratories - Break up of Revenue by Reportable Business Segment (%), 2014
Figure 9-2: Alere Inc. - Break up of Revenue by Reportable Business Segment (%), 2014
Figure 9-3: Alere Inc. - Professional Diagnostic Division Revenue by Segment (%), 2014
Figure 9-4: Becton, Dickinson and Company - Break up of Revenue by Business Segment (%), 2014
Figure 9-5: Becton, Dickinson and Company - Diagnostic Division Revenue by Segment (%), 2014
Figure 9-6: bioMérieux SA - Break up of Revenue by Applications (%), 2014
Figure 9-7: bioMérieux SA - Clinical Application Revenue by Segment (%), 2014
Figure 9-8: Cepheid - Break up of Revenue by Business Segment (%), 2014
Figure 9-9: Danaher Corporation - Break up of Revenue by Business Segment (%), 2014
Figure 9-10: Roche AG - Break up of Revenue by Business Segment (%), 2014
Figure 9-11: Roche AG - Diagnostic Division Revenue by Segment (%), 2014
Figure 9-12: Hologic, Inc. - Break up of Revenue by Business Segment (%), 2015
Figure 9-13: Hologic, Inc. - Diagnostic Division Revenue by Segment (%), 2015
Figure 9-14: QIAGEN N.V. - Break up of Revenue by Business Segment (%), 2014
Figure 9-15: Thermo Fisher Scientific Inc. - Break up of Revenue by Business Segment (%), 2014
Figure 5-1: Global - Molecular Diagnostics Market (Billion US$), 2015-2020
Figure 6-1: Global - Molecular Diagnostics Market by Application (%), 2015
Figure 6-2: Global - Molecular Diagnostics Market by Application (%), 2020
Figure 6-3: Global - Infectious Disease Market (Billion US$), 2015-2020
Figure 6-4: Global - Oncology Market (Billion US$), 2015-2020
Figure 6-5: Global - Blood Screening Market (Billion US$), 2015-2020
Figure 6-6: Global - Genetic Testing Market (Billion US$), 2015-2020
Figure 7-1: Global - Molecular Diagnostics Market by Technology (%), 2015
Figure 7-2: Global - Molecular Diagnostics Market by Technology (%), 2020
Figure 7-3: Global - PCR Market (Billion US$), 2015-2020
Figure 7-4: Global - Nucleic Acid Hybridization Market (Billion US$), 2015-2020
Figure 7-5: Global - DNA Sequencing and NGS Market (Billion US$), 2015-2020
Figure 8-1: Global - Molecular Diagnostics Market by Region (%), 2015
Figure 8-2: Global - Molecular Diagnostics Market by Region (%), 2020
Figure 8-3: North America - Molecular Diagnostics Market (Billion US$), 2015-2020
Figure 8-4: North America - Molecular Diagnostics Market by Country (%), 2015
Figure 8-5: Europe - Molecular Diagnostics Market (Billion US$), 2015-2020
Figure 8-6: Europe - Molecular Diagnostics Market by Country (%), 2015
Figure 8-7: Asia Pacific - Molecular Diagnostics Market (Billion US$), 2015-2020
Figure 8-8: Asia Pacific - Molecular Diagnostics Market by Country (%), 2015
Figure 9-1: Abbott Laboratories - Break up of Revenue by Reportable Business Segment (%), 2014
Figure 9-2: Alere Inc. - Break up of Revenue by Reportable Business Segment (%), 2014
Figure 9-3: Alere Inc. - Professional Diagnostic Division Revenue by Segment (%), 2014
Figure 9-4: Becton, Dickinson and Company - Break up of Revenue by Business Segment (%), 2014
Figure 9-5: Becton, Dickinson and Company - Diagnostic Division Revenue by Segment (%), 2014
Figure 9-6: bioMérieux SA - Break up of Revenue by Applications (%), 2014
Figure 9-7: bioMérieux SA - Clinical Application Revenue by Segment (%), 2014
Figure 9-8: Cepheid - Break up of Revenue by Business Segment (%), 2014
Figure 9-9: Danaher Corporation - Break up of Revenue by Business Segment (%), 2014
Figure 9-10: Roche AG - Break up of Revenue by Business Segment (%), 2014
Figure 9-11: Roche AG - Diagnostic Division Revenue by Segment (%), 2014
Figure 9-12: Hologic, Inc. - Break up of Revenue by Business Segment (%), 2015
Figure 9-13: Hologic, Inc. - Diagnostic Division Revenue by Segment (%), 2015
Figure 9-14: QIAGEN N.V. - Break up of Revenue by Business Segment (%), 2014
Figure 9-15: Thermo Fisher Scientific Inc. - Break up of Revenue by Business Segment (%), 2014
LIST OF TABLES:
Table 6-1: Global - Molecular Diagnostic Market by Application (Billion US$), 2015
Table 6-2: Global - Molecular Diagnostic Market by Application (Billion US$), 2020
Table 7-1: Global - Molecular Diagnostic Market by Technology (Billion US$), 2015
Table 7-2: Global - Molecular Diagnostic Market by Technology (Billion US$), 2020
Table 8-1: Global - Molecular Diagnostic Market by Region (Billion US$), 2015
Table 8-2: Global - Molecular Diagnostic Market by Region (Billion US$), 2020
Table 9-1: Abbott Laboratories - Key Financials (Million US$), 2012-2014
Table 9-2: Abbott Diagnostics - Product Portfolio for Molecular Diagnostics
Table 9-3: Alere Inc. - Key Financials (Million US$), 2012-2014
Table 9-4: Alere Inc. - Product Portfolio for Molecular Diagnostics
Table 9-5: Becton, Dickinson and Company - Key Financials (Million US$), 2012-2014
Table 9-6: Becton, Dickinson and Company - Product Portfolio for Molecular Diagnostics
Table 9-7: bioMérieux SA - Key Financials (Million US$) 2012-2014
Table 9-8: bioMérieux SA - Product Portfolio for Molecular Diagnostics
Table 9-9: Cepheid - Key Financials (Million US$), 2012-2014
Table 9-10: Cepheid - Product Portfolio for Molecular Diagnostics
Table 9-11: Danaher Corporation - Key Financials (Million US$) 2012-2014
Table 9-12: Danaher Corporation - Product Portfolio for Molecular Diagnostics
Table 9-13: Roche AG - Key Financials (Million US$), 2012-2014
Table 9-14: Roche AG - Product Portfolio for Molecular Diagnostics
Table 9-15: Hologic, Inc. - Key Financials (Million US$) 2013-2015
Table 9-16: Hologic, Inc. - Product Portfolio for Molecular Diagnostics
Table 9-17: QIAGEN N.V. - Key Financials (Million US$), 2012-2014
Table 9-18: QIAGEN N.V. - Product Portfolio for Molecular Diagnostics
Table 9-19: Siemens Healthcare - Key Financials (Million US$), 2012-2014
Table 9-20: Siemens Healthcare - Product Portfolio for Molecular Diagnostics
Table 9-21: Thermo Fisher Scientific Inc. - Key Financials (Million US$) 2012-2014
Table 9-22: Thermo Fisher Scientific Inc. - Product Portfolio for Molecular Diagnostics
Table 6-1: Global - Molecular Diagnostic Market by Application (Billion US$), 2015
Table 6-2: Global - Molecular Diagnostic Market by Application (Billion US$), 2020
Table 7-1: Global - Molecular Diagnostic Market by Technology (Billion US$), 2015
Table 7-2: Global - Molecular Diagnostic Market by Technology (Billion US$), 2020
Table 8-1: Global - Molecular Diagnostic Market by Region (Billion US$), 2015
Table 8-2: Global - Molecular Diagnostic Market by Region (Billion US$), 2020
Table 9-1: Abbott Laboratories - Key Financials (Million US$), 2012-2014
Table 9-2: Abbott Diagnostics - Product Portfolio for Molecular Diagnostics
Table 9-3: Alere Inc. - Key Financials (Million US$), 2012-2014
Table 9-4: Alere Inc. - Product Portfolio for Molecular Diagnostics
Table 9-5: Becton, Dickinson and Company - Key Financials (Million US$), 2012-2014
Table 9-6: Becton, Dickinson and Company - Product Portfolio for Molecular Diagnostics
Table 9-7: bioMérieux SA - Key Financials (Million US$) 2012-2014
Table 9-8: bioMérieux SA - Product Portfolio for Molecular Diagnostics
Table 9-9: Cepheid - Key Financials (Million US$), 2012-2014
Table 9-10: Cepheid - Product Portfolio for Molecular Diagnostics
Table 9-11: Danaher Corporation - Key Financials (Million US$) 2012-2014
Table 9-12: Danaher Corporation - Product Portfolio for Molecular Diagnostics
Table 9-13: Roche AG - Key Financials (Million US$), 2012-2014
Table 9-14: Roche AG - Product Portfolio for Molecular Diagnostics
Table 9-15: Hologic, Inc. - Key Financials (Million US$) 2013-2015
Table 9-16: Hologic, Inc. - Product Portfolio for Molecular Diagnostics
Table 9-17: QIAGEN N.V. - Key Financials (Million US$), 2012-2014
Table 9-18: QIAGEN N.V. - Product Portfolio for Molecular Diagnostics
Table 9-19: Siemens Healthcare - Key Financials (Million US$), 2012-2014
Table 9-20: Siemens Healthcare - Product Portfolio for Molecular Diagnostics
Table 9-21: Thermo Fisher Scientific Inc. - Key Financials (Million US$) 2012-2014
Table 9-22: Thermo Fisher Scientific Inc. - Product Portfolio for Molecular Diagnostics
